In vitrosynergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells

被引：0
|
作者：
A Ugur Ural
Ferit Avcu
Muhammed Candir
Metin Guden
M Ali Ozcan
机构：
[1] Gulhane Military Medical Faculty,Department of Hematology
[2] Gulhane Military Medical Faculty,Department of Medical and Cancer Research Center
[3] Gulhane Military Medical Faculty,Department of Internal Medicine
[4] Gulhane Military Medical Faculty,Department of Radiation Oncology
[5] Medical Faculty of Dokuz Eylul University,Department of Hematology
来源：
Breast Cancer Research | / 8卷
关键词：
Breast Cancer Cell; Bone Metastasis; Zoledronic Acid; Combination Index; Farnesyl Pyrophosphate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Zoledronic acid 'benefits women with early breast cancer'
    Gnant, Michael
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1615 - 1615
  • [42] Zoledronic acid in adjuvant treatment of early breast cancer
    Alonso, B
    Alemán, R
    Rguez, LM
    Llanos, M
    Rguez, E
    Cruz, J
    Oramas, J
    Batista, JN
    [J]. BONE, 2006, 38 (03) : S65 - S65
  • [43] The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
    Jagdev, SP
    Coleman, RE
    Shipman, CM
    Rostami-H, A
    Croucher, PI
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (08) : 1126 - 1134
  • [44] Zoledronic acid affects the ability of mesenchymal stem cells to sustain breast cancer progression
    Normanno, N.
    Gallo, M.
    Lamura, L.
    De Luca, A.
    [J]. EJC SUPPLEMENTS, 2009, 7 (03): : 17 - 17
  • [45] Migrating breast cancer stem-like cells are slowed down by zoledronic acid
    Buehler, H.
    Hoberg, C.
    NguemgoKouam, P.
    Fakhrian, K.
    Adamietz, I. A.
    [J]. FEBS JOURNAL, 2014, 281 : 779 - 780
  • [46] New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
    C Denoyelle
    L Hong
    J-P Vannier
    J Soria
    C Soria
    [J]. British Journal of Cancer, 2003, 88 : 1631 - 1640
  • [47] Zoledronic acid (ZOL) in combination with doxorubicin (DOX) has synergistic effects on apoptosis of breast cancer cells (BCCs) in vitro
    Neville-Webbe, HL
    Evans, CA
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1598 - 1598
  • [48] New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
    Denoyelle, C
    Hong, L
    Vannier, JP
    Soria, J
    Soria, C
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (10) : 1631 - 1640
  • [49] Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer
    Sugie, Tomoharu
    Suzuki, Eiji
    Yamauchi, Akira
    Yamagami, Kazuhiko
    Masuda, Norikazu
    Gondo, Naomi
    Sumi, Eriko
    Ikeda, Takafumi
    Tada, Harue
    Uozumi, Ryuji
    Kanao, Shotaro
    Tanaka, Yoshimasa
    Hamazaki, Yoko
    Minato, Nagahiro
    Toi, Masakazu
    [J]. BREAST, 2018, 38 : 114 - 119
  • [50] Human stromal cells are required for an anti-breast cancer effect of zoledronic acid
    Nienhuis, Hilde H.
    Arjaans, Marlous
    Timmer-Bosscha, Hetty
    de Vries, Elisabeth G. E.
    Schroder, Carolina P.
    [J]. ONCOTARGET, 2015, 6 (27) : 24436 - 24447
12345